In 2013, the Progressive MS Alliance brought together MS experts to identify the priorities to overcoming the barriers to progress. As a result, the Alliance is focused on four research priority areas needed to provide the breakthrough treatments:
- Better understand progression so we can identify and test treatments
- Design shorter, faster trials that measure patient outcomes
- Conduct trials to test agents
- Develop and evaluate new therapies to manage symptoms
We issued our first request for applications from MS researchers in 2013. Following a rigorous evaluation, we decided to fund 20 Challenge Awards covering topics such as rehabilitation, new diagnostic tests and repurposing of existing drugs.
We have now issued our second request for applications, for the Collaborative Network Awards.
In this section you can find out more about the principles underlying our research, and the types of research we intend to fund.
Watch this interview with Alan Thompson, the chair of our Scientific Steering Committee, to find out more about research into Progressive MS: